Literature DB >> 32206960

Cryopreservation of euploid blastocysts obtained after fertilization of in vitro matured ovarian tissue oocytes: a case report.

Anastasia Kirillova1, Evgeniya Kovalskaya2, Olga Brovkina3, Aleksey Ekimov2, Ekaterina Bunyaeva2, Marat Gordiev4, Nona Mishieva2, Tatiana Nazarenko2, Aydar Abubakirov2, Gennady Sukikh2.   

Abstract

With the increased rate of stable remission after gonadotoxic cancer treatment, new methods of fertility preservation are required in order to provide the best possible care for oncological patients. Here, we report an original case of euploid blastocyst cryopreservation after in vitro maturation of ovarian tissue oocytes (OTO IVM). Thirty-three oocytes were obtained from the ovarian tissue after ovariectomy in the breast cancer patient. Six out of 12 matured oocytes fertilized successfully and 3 blastocysts were formed. Genetic investigation for mutations associated with this type of malignancy found that the patient is not a carrier. Preimplantation genetic testing was performed only for aneuploidies and found all 3 blastocysts to be euploid and suitable for embryo transfer. Our study showed that the ovarian tissue oocytes matured in vitro have the potential for euploid blastocyst formation after ICSI which could be screened for aneuploidies and inherited mutations and then be vitrified in order to provide the best fertility preservation strategy for women with cancer.

Entities:  

Keywords:  Blastocyst formation; Breast cancer; Case report; Fertility preservation; In vitro maturation (IVM),; Preimplantation genetic screening

Mesh:

Year:  2020        PMID: 32206960      PMCID: PMC7183014          DOI: 10.1007/s10815-020-01729-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  47 in total

1.  Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls.

Authors:  Kathryn J Ruddy; Shari Gelber; Elizabeth S Ginsburg; Lidia Schapira; Mary E Abusief; Meghan E Meyer; Ann H Partridge
Journal:  Menopause       Date:  2011-01       Impact factor: 2.953

2.  Safety of ovarian tissue transplantation in patients with borderline ovarian tumors.

Authors:  Rossella Masciangelo; Chiara Bosisio; Jacques Donnez; Christiani A Amorim; Marie-Madeleine Dolmans
Journal:  Hum Reprod       Date:  2018-02-01       Impact factor: 6.918

3.  Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation.

Authors:  Alon Kedem; Gil M Yerushalmi; Masha Brengauz; Hila Raanani; Raoul Orvieto; Ariel Hourvitz; Dror Meirow
Journal:  J Assist Reprod Genet       Date:  2018-03-24       Impact factor: 3.412

4.  Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer.

Authors:  Mikkel Rosendahl; Vera Timmermans Wielenga; Lotte Nedergaard; Stine Gry Kristensen; Erik Ernst; Per Emil Rasmussen; Michael Anderson; Kirsten Tryde Schmidt; Claus Yding Andersen
Journal:  Fertil Steril       Date:  2011-01-12       Impact factor: 7.329

5.  Eliminating malignant cells from cryopreserved ovarian tissue is possible in leukaemia patients.

Authors:  Michelle Soares; Pascale Saussoy; Mathilde Maskens; Hélène Reul; Christiani A Amorim; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Br J Haematol       Date:  2017-04-17       Impact factor: 6.998

6.  In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe.

Authors:  Ingrid Segers; Ileana Mateizel; Ellen Van Moer; Johan Smitz; Herman Tournaye; Greta Verheyen; Michel De Vos
Journal:  J Assist Reprod Genet       Date:  2015-08-08       Impact factor: 3.412

Review 7.  Maturation in vitro of immature human oocytes for clinical use.

Authors:  K Y Cha; R C Chian
Journal:  Hum Reprod Update       Date:  1998 Mar-Apr       Impact factor: 15.610

Review 8.  Basic and Clinical Approaches for Fertility Preservation and Restoration in Cancer Patients.

Authors:  Jose V Medrano; María Del Mar Andrés; Sofía García; Sonia Herraiz; Teresa Vilanova-Pérez; Ellen Goossens; Antonio Pellicer
Journal:  Trends Biotechnol       Date:  2017-11-15       Impact factor: 19.536

9.  Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.

Authors:  Jack Y J Huang; Togas Tulandi; Hananel Holzer; Seang Lin Tan; Ri-Cheng Chian
Journal:  Fertil Steril       Date:  2007-06-04       Impact factor: 7.329

10.  Clinical reassessment of human embryo ploidy status between cleavage and blastocyst stage by Next Generation Sequencing.

Authors:  Alberto Liñán; Barbara Lawrenz; Ibrahim El Khatib; Asina Bayram; Ana Arnanz; Carmen Rubio; Rupali Chopra; Human M Fatemi
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

View more
  2 in total

1.  Twenty-first century oocyte cryopreservation-in vitro maturation of immature oocytes from ovarian tissue cryopreservation in cancer patients: A systematic review.

Authors:  Ahmad Mohd Faizal; Yodo Sugishita; Yuki Suzuki-Takahashi; Hideyuki Iwahata; Seido Takae; Yuki Horage-Okutsu; Nao Suzuki
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

2.  Improved maturation competence of ovarian tissue oocytes using a biphasic in vitro maturation system for patients with gynecological malignancy: a study on sibling oocytes.

Authors:  Anastasia Kirillova; Ekaterina Bunyaeva; Heidi Van Ranst; Grigory Khabas; Maria Farmakovskaya; Nail Kamaletdinov; Tatiana Nazarenko; Aydar Abubakirov; Gennady Sukhikh; Johan E J Smitz
Journal:  J Assist Reprod Genet       Date:  2021-02-22       Impact factor: 3.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.